10 Apr, 2026

Winners And Losers Of Q4: Sally Beauty (NYSE:SBH) Vs The Rest Of The Beauty and Cosmetics Retailer Stocks

Let’s dig into the relative performance of Sally Beauty (NYSE:SBH) and its peers as we unravel the now-completed Q4 beauty and cosmetics retailer earnings season. Beauty and cosmetics retailers understand that beauty is in the eye of the beholder, but a little lipstick, nail polish, and glowing skin also help the cause. These stores—which mostly cater to consumers but can also garner the attention of salon pros—aim to be a one-stop personal care and beauty products shop with many brands across many categories. E-commerce is changing how consumers buy cosmetics, so these retailers are constantly evolving to meet the customer where and how they want to shop. The 4 beauty and cosmetics retailer stocks we track reported a mixed Q4. As a group, revenues beat analysts’ consensus estimates by 1.5% while next quarter’s revenue guidance was in line. Amidst this news, share prices of the companies have had a rough stretch. On average, they are down 11.7% since the latest earnings results. Sally Beauty (NYSE:SBH) Catering to both everyday consumers as well as salon professionals, Sally Beauty (NYSE:SBH) is a retailer that sells salon-quality beauty products such as makeup and haircare products. Sally Beauty reported revenues of $943.2 million, flat year on year. This print was in line with analysts’ expectations, but overall, it was a mixed quarter for the company with a decent beat of analysts’ EBITDA estimates but EPS guidance for next quarter missing analysts’ expectations significantly. Sally Beauty Total Revenue Sally Beauty pulled off the highest full-year guidance raise of the whole group. Still, the market seems discontent with the results. The stock is down 17.6% since reporting and currently trades at $14.46. Read our full report on Sally Beauty here, it’s free. Best Q4: Bath and Body Works (NYSE:BBWI) Spun off from L Brands in 2020, Bath & Body Works (NYSE:BBWI) is a personal care and home fragrance retailer where consumers can find specialty shower gels, scented candles for the home, and lotions. Bath and Body Works reported revenues of $2.72 billion, down 2.3% year on year, outperforming analysts’ expectations by 4.3%. The business had an exceptional quarter with EPS guidance for next quarter exceeding analysts’ expectations and an impressive beat of analysts’ EBITDA estimates. Bath and Body Works Total Revenue Bath and Body Works achieved the biggest analyst estimates beat among its peers. Although it had a fine quarter compared to its peers, the market seems unhappy with the results as the stock is down 17.6% since reporting. It currently trades at $18.48. Is now the time to buy Bath and Body Works? Access our full analysis of the earnings results here, it’s free.